Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
5.26
+0.48 (9.94%)
Nov 4, 2024, 12:59 PM EST - Market open
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for TMCI stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 33.21% from the current stock price of 5.26.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for TMCI stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 7 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $7.5 → $6 | Hold | Maintains | $7.5 → $6 | +14.18% | Oct 14, 2024 |
| UBS | UBS | Hold Maintains $6.5 → $7 | Hold | Maintains | $6.5 → $7 | +33.21% | Aug 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $9 → $7.5 | Hold | Maintains | $9 → $7.5 | +42.72% | Aug 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $7 → $9 | Hold | Maintains | $7 → $9 | +71.27% | Jul 16, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $5.5 → $8 | Hold | Maintains | $5.5 → $8 | +52.24% | Jul 15, 2024 |
Financial Forecast
Revenue This Year
210.09M
from 187.12M
Increased by 12.28%
Revenue Next Year
232.22M
from 210.09M
Increased by 10.53%
EPS This Year
-0.96
from -0.81
EPS Next Year
-0.80
from -0.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 217.4M | 248.9M | 277.2M | ||
| Avg | 210.1M | 232.2M | 256.4M | ||
| Low | 200.7M | 217.5M | 234.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.2% | 18.4% | 19.4% | ||
| Avg | 12.3% | 10.5% | 10.4% | ||
| Low | 7.3% | 3.5% | 1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.95 | -0.70 | -0.60 | ||
| Avg | -0.96 | -0.80 | -0.69 | ||
| Low | -0.96 | -0.94 | -0.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.